[Tyr0] Atriopeptin II

[Tyr0] Atriopeptin II is a tyrosine-extended natriuretic peptide analog enabling labeling and quantitative detection. The extra residue minimally perturbs the core ring structure that underlies receptor interaction. Its physicochemical properties aid studies on natriuretic peptide receptor binding and cyclic peptide folding. Researchers employ it in cardiovascular peptide signaling research models.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: A17020

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C107H165N35O34S2
M.W/Mr.
2549.9
Sequence
YSSCFGGRIDRIGAQSGLGCNSFR
Length
24

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Analysis ServicesPeptide Nucleic Acids SynthesisCustom Conjugation ServicecGMP Peptide ServiceEpitope Mapping ServicesPeptide Modification ServicesPeptide Synthesis ServicesPeptide CDMO
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers